Acepodia Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 39

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $100M

  • Investors
  • 1

Acepodia General Information

Description

Acepodia Inc is a clinical stage biotechnology company engaged to develop first-in-class cell therapies by using the Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1600 Harbor Bay Parkway
  • Suite 140
  • Alameda, CA 94502
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1600 Harbor Bay Parkway
  • Suite 140
  • Alameda, CA 94502
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acepodia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 06-Jun-2023 $100M Completed Generating Revenue
6. Later Stage VC (Series C) 02-Dec-2021 Completed Clinical Trials - Phase 1
5. Later Stage VC (Series B) 16-Mar-2021 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series A) 11-Sep-2019 Completed Startup
3. Early Stage VC 01-Jan-2017 Completed Startup
2. Early Stage VC (Series A) 01-Jan-2015 $10M $10M Completed Startup
1. Grant 01-Jan-2014 $350K Completed Startup
To view Acepodia’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Acepodia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Acepodia Inc is a clinical stage biotechnology company engaged to develop first-in-class cell therapies by using the Ant
Drug Discovery
Alameda, CA
39 As of 2025

Shanghai, China
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acepodia Competitors (44)

One of Acepodia’s 44 competitors is JW Therapeutics, a Formerly VC-backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
JW Therapeutics Formerly VC-backed Shanghai, China
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Phio Pharmaceuticals Formerly Accelerator/Incubator backed King of Prussia, PA
Sorrento Therapeutics Formerly VC-backed San Diego, CA
ArsenalBio Venture Capital-Backed South San Francisco, CA
You’re viewing 5 of 44 competitors. Get the full list »

Acepodia Patents

Acepodia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4823628-A1 A novel antibody conjugate, and uses thereof Pending 30-May-2024
WO-2025250579-A1 A novel antibody conjugate, and uses thereof Pending 30-May-2024
EP-4448730-A1 A novel method of treating targeted abnormal cells, and cytotoxic cell used therein Pending 13-Dec-2021
WO-2023114719-A1 A novel method of treating targeted abnormal cells, and cytotoxic cell used therein Inactive 13-Dec-2021
EP-4322972-A1 Novel compositions enriched in gamma delta t cells, methods of preparation, and uses thereof Pending 16-Apr-2021 A61K40/33
To view Acepodia’s complete patent history, request access »

Acepodia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acepodia Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Center Laboratories Accelerator/Incubator Minority
To view Acepodia’s complete investors history, request access »

Acepodia ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Acepodia’s complete esg history, request access »

Acepodia FAQs

  • When was Acepodia founded?

    Acepodia was founded in 2014.

  • Where is Acepodia headquartered?

    Acepodia is headquartered in Alameda, CA.

  • What is the size of Acepodia?

    Acepodia has 39 total employees.

  • What industry is Acepodia in?

    Acepodia’s primary industry is Drug Discovery.

  • Is Acepodia a private or public company?

    Acepodia is a Private company.

  • What is Acepodia’s current revenue?

    The current revenue for Acepodia is .

  • How much funding has Acepodia raised over time?

    Acepodia has raised $268M.

  • Who are Acepodia’s investors?

    Center Laboratories has invested in Acepodia.

  • Who are Acepodia’s competitors?

    JW Therapeutics, CytomX Therapeutics, Phio Pharmaceuticals, Sorrento Therapeutics, and ArsenalBio are some of the 44 competitors of Acepodia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process